North America Point-Of-Care Diagnostics Market is registering a CAGR of 9.42% in the forecast period of 2021 to 2028.
North America Point-Of-Care Diagnostics Market is registering a CAGR of 9.42% in the forecast period of 2021 to 2028.
North America Point-Of-Care Diagnostics Market Scope and Size
North America point-of-care diagnostics market is segmented on the basis of product, platform, prescription and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications.
- On the basis of product, the North America point-of-care diagnostics market is segmented into glucose monitoring products, cardio metabolic, infectious disease, coagulation, pregnancy and fertility, tumour or cancer marker, urinalysis, cholesterol, haematology, drugs-of-abuse, fecal occult and others. Glucose monitoring products is further sub segmented into strips, meters and lancets and lancing device. Cardiometabolic is further sub segmented into cardiac marker, blood gas or electrolytes and HBA1C. Infectious disease is further sub segmented into influenza, HIV, hepatitis C, sexually transmitted disease (STD), healthcare-associated infection (HAI), respiratory infection, tropical disease and other infectious disease. Coagulation is further sub segmented into PT or INR and activated clotting time (ACT or APTT). Pregnancy and fertility is further sub segmented into pregnancy test and fertility test.
- On the basis of platform, the North America point-of-care diagnostics market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics and immunoassays.
- On the basis of prescription, the North America point-of-care diagnostics market is segmented into prescription-based testing and OTC testing.
- On the basis of end user, the North America point-of-care diagnostics market is segmented into clinical laboratories, outpatient healthcare and ambulatory care settings, hospitals or critical care centres, home care, research laboratories and other.
Get free sample copy of Report here:
Market Analysis and Insights - North America Point-Of-Care Diagnostics Market
U.S. and Canada dominate the North America point-of-care diagnostics market due to the swift rise in the COVID-19 cases. Furthermore, the growing awareness regarding self-testing and home care goods will further boost the North America point-of-care diagnostics market during the forecast period.
North America Point-Of-Care Diagnostics Market Country Level Analysis
The countries covered in the North America point-of-care diagnostics market report are the U.S., Canada, and Mexico in North America.
Key Players North America Point-Of-Care Diagnostics Market
Some of the major players operating in the North America Point-Of-Care Diagnostics Market are:
- Abbott
- Danaher
- BD
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson Services
- Instrumentation Laboratory S.p.A.
Download Full Access of Report Now @
MAJOR TOC OF THE REPORT
Chapter One: Introduction
Chapter Two: Market Segmentation
Chapter Three: Market Overview
Chapter Four: Executive Summary
Chapter Five: Premium Insights
Chapter Six: North America Point-Of-Care Diagnostics Market by Product & Procedure type.
Get TOC Details:
Browse Related Reports@
Point-Of-Care Diagnostics Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
